Acute heart failure: inotropic agents and their clinical uses, Expert Opin Pharmacother, vol.7, pp.2179-2202, 2006. ,
Mechanism of action of Ca2+ sensitizers -update, Cardiovasc Drugs Ther, vol.15, pp.397-403, 2001. ,
The contractile apparatus as a target for drugs against heart failure: interaction of levosimendan, a calcium sensitiser, with cardiac troponin c, Mol Cell Biochem, vol.266, pp.87-107, 2004. ,
SR33805, a Ca2+ antagonist with length-dependent Ca2+ -sensitizing properties in cardiac myocytes, Br J Pharmacol, vol.139, pp.99-108, 2003. ,
URL : https://hal.archives-ouvertes.fr/hal-01824393
Characterization of the binding of [3H]SR 33805 to the slow Ca2+ channel in rat heart sarcolemmal membrane, Eur J Pharmacol, vol.267, pp.151-160, 1994. ,
In vitro characterization of a novel Ca2+ entry blocker: SR 33805, Eur J Pharmacol, vol.246, pp.181-193, 1993. ,
Alteration of the [Ca(2+)](i)-force relationship during the vasorelaxation induced by a Ca(2+) channel blocker SR33805 in the porcine coronary artery, Br J Pharmacol, vol.131, pp.1597-1606, 2000. ,
Calcium, thin filaments, and the integrative biology of cardiac contractility, Annu Rev Physiol, vol.67, pp.39-67, 2005. ,
Late exercise training improves non-uniformity of transmural myocardial function in rats with ischaemic heart failure, Cardiovasc Res, vol.81, pp.555-564, 2009. ,
URL : https://hal.archives-ouvertes.fr/hal-01824366
Transmural stretchdependent regulation of contractile properties in rat heart and its alteration after myocardial infarction, FASEB J, vol.19, pp.88-90, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-01824390
Cardiac thin filament regulation, Pflugers Arch, vol.457, pp.37-46, 2008. ,
Late-stage alterations in myofibrillar contractile function in a transgenic mouse model of dilated cardiomyopathy (Tgalphaq*44), J Mol Cell Cardiol, vol.45, pp.363-372, 2008. ,
Increasing cardiac contractility after myocardial infarction exacerbates cardiac injury and pump dysfunction, Circ Res, vol.107, pp.800-809, 2010. ,
Cardiac Ca2+ signaling and Ca2+ sensitizers, Circ J, vol.72, pp.1915-1925, 2008. ,
Myofilament calcium sensitization delays decompensated hypertrophy differently between the sexes following myocardial infarction, Am J Physiol Regul Integr Comp Physiol, vol.300, pp.361-368, 2011. ,
Effects of a new class of calcium antagonists, SR33557 (fantofarone) and SR33805, on neuronal voltage-activated Ca++ channels, J Pharmacol Exp Ther, vol.271, pp.1348-1352, 1994. ,
Slow contractions characterize failing rat hearts, Basic Res Cardiol, vol.103, pp.328-344, 2008. ,
Relationship between K+ channel down-regulation and [Ca2+]i in rat ventricular myocytes following myocardial infarction, J Physiol, vol.517, pp.229-245, 1999. ,
EMD 53998 sensitizes the contractile proteins to calcium in intact ferret ventricular muscle, Circ Res, vol.69, pp.927-936, 1991. ,
Differential effects of the optical isomers of EMD 53998 on contraction and cytoplasmic Ca2+ in isolated ferret cardiac muscle, Circ Res, vol.73, pp.61-70, 1993. ,
Ca++ sensitizers impair cardiac relaxation in failing human myocardium, J Pharmacol Exp Ther, vol.280, pp.247-254, 1997. ,
Stereoselective actions of thiadiazinones on canine cardiac myocytes and myofilaments, Circ Res, vol.73, pp.981-990, 1993. ,
Levosimendan: a parenteral calcium-sensitising drug with additional vasodilatory properties, Expert Opin Investig Drugs, vol.10, pp.955-970, 2001. ,
Orally available levosimendan dose-related positive inotropic and lusitropic effect in conscious chronically instrumented normal and heart failure dogs, J Pharmacol Exp Ther, vol.325, pp.236-247, 2008. ,
Identification of cardiac-specific myosin light chain kinase, Circ Res, vol.102, pp.571-580, 2008. ,
Ca(2+)-induced Ca(2+) entry' or how the L-type Ca(2+) channel remodels its own signalling pathway in cardiac cells, Prog Biophys Mol Biol, vol.90, pp.118-135, 2006. ,
Attenuation of length dependence of calcium activation in myofilaments of transgenic mouse hearts expressing slow skeletal troponin I, J Physiol, vol.526, pp.541-549, 2000. ,
Protein kinase C and A sites on troponin I regulate myofilament Ca2+ sensitivity and ATPase activity in the mouse myocardium, J Physiol, vol.552, pp.845-857, 2003. ,
Tuning the human heart molecular motors by myosin light chains, J Mol Med, vol.77, pp.544-555, 1999. ,
Effects of protein kinase A phosphorylation on signaling between cardiac troponin I and the N-terminal domain of cardiac troponin C, Biochemistry, vol.36, pp.13305-13311, 1997. ,
Potential novel pharmacological therapies for myocardial remodelling, Cardiovasc Res, vol.81, pp.519-527, 2009. ,
Calcium and cardiac rhythms: physiological and pathophysiological, Circ Res, vol.90, pp.14-17, 2002. ,
Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension, J Muscle Res Cell Motil, vol.27, pp.435-444, 2006. ,
Myofibrillar calcium sensitivity of isometric tension is increased in human dilated cardiomyopathies: role of altered beta-adrenergically mediated protein phosphorylation, J Clin Invest, vol.98, pp.167-176, 1996. ,
Sarcomeric dysfunction in heart failure, Cardiovasc Res, vol.77, pp.649-658, 2008. ,
Effects of the Ca2+ sensitizers EMD 57033 and CGP 48506 on myocardial contractility and Ca2+ transients in human ventricular and atrial myocardium, Z Kardiol, vol.91, pp.312-318, 2002. ,
The effects of levosimendan on the left ventricular function and protein phosphorylation in post-ischemic guinea pig hearts, Basic Res Cardiol, vol.94, pp.223-230, 1999. ,
Intracellular localization and functional effects of P21-activated kinase-1 (Pak1) in cardiac myocytes, Circ Res, vol.94, pp.194-200, 2004. ,
COMMD1 downregulates the epithelial sodium channel through Nedd4 -2, Am J Physiol Renal Physiol, vol.298, pp.1445-1456, 2010. ,
Activation of beta2-adrenergic receptors hastens relaxation and mediates phosphorylation of phospholamban, troponin I, and C-protein in ventricular myocardium from patients with terminal heart failure, Circulation, vol.99, pp.65-72, 1999. ,
Troponin phosphorylation and myofilament Ca2+-sensitivity in heart failure: increased or decreased?, J Mol Cell Cardiol, vol.45, pp.603-607, 2008. ,
Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction, Eur Heart J, vol.30, pp.1863-1872, 2009. ,